Estradiol Tablet bulk supplier for pharma manufacturers

Estradiol Tablet 0.5 mg, 1 mg, 2 mg Suppliers & Bulk Manufacturers

Available Forms: Oral tablets

Available Strengths: 0.5 mg, 1 mg, 2 mg

Reference Brands: Estrace®(US), Estrofem®(EU)

Estradiol tablets are essential in hormone replacement therapy and women’s health. Available in strengths from 0.5 mg to 2 mg, top brands like Estrace®, Estrofem®, and Femoston® serve US and EU markets. Trusted for treating menopause symptoms and estrogen deficiency, estradiol tablets are widely distributed to hospitals, pharmacies, and clinics. A reliable choice for pharmaceutical wholesalers and HRT product portfolios.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Leading B2B pharmaceutical suppliers in the US and EU offer quality estradiol tablets for hormone replacement therapy (HRT) and estrogen deficiency treatment. Trusted brands such as Estrace®, Estrofem®, Femoston®, and generic estradiol provide strengths ranging from 0.5 mg to 2 mg per tablet. Available in oral tablet form, these FDA- and EMA-approved products deliver consistent dosing and bioavailability. Ideal for menopause symptom relief, osteoporosis prevention, and gynecological indications, estradiol tablets meet stringent GMP standards. Connect with our network of distributors, pharmacies, and healthcare providers to secure reliable supply chains and pricing for premium estradiol therapies across the US and Europe.

Estradiol Tablet — third party manufacturing & bulk supply

Estradiol Tablet 0.5 mg, 1 mg, 2 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Estradiol Tablet is supplied as Oral tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Estradiol Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Estradiol Tablet →

Back to Listing

Frequently Asked Questions

Estradiol is used for hormone replacement therapy in women, especially to manage menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. It is also prescribed for estrogen deficiency, certain menstrual disorders, and prevention of postmenopausal osteoporosis. In some cases, it may be used in hormone therapy regimens under medical supervision.

Estradiol medicines are made from estradiol hemihydrate or estradiol valerate, which are forms of the natural estrogen hormone identical or very similar to the estrogen produced by the ovaries. The medicine helps restore estrogen levels in the body.

Common trade names include Progynova, Estrace, and Estrofem, which are marketed in different regions including the USA, Europe, and other global pharmaceutical markets.

Estradiol products are manufactured by several pharmaceutical companies worldwide, including Bayer and Novo Nordisk along with other global manufacturers supplying hormone therapy medicines.

The generic name is estradiol hemihydrate or estradiol valerate depending on the formulation.

Brand names include Progynova, Estrace, and Estrofem.

Estradiol products are manufactured in multiple countries including the United States, Germany and other European Union countries, India, and additional pharmaceutical manufacturing hubs that produce hormone therapy medicines under approved regulatory standards.